Search Results - "Etemadifar, Masoud"

Refine Results
  1. 1
  2. 2

    Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model by Najarzadegan, Niloofar, Madani, Mahboobeh, Etemadifar, Masoud, Sedaghat, Nahad

    Published in PloS one (07-12-2022)
    “…Fingolimod (FTY720) is a drug derived from the fungicidal compound myriocin. As it was unclear whether FTY720 has antifungal effects as well, we aimed to…”
    Get full text
    Journal Article
  3. 3

    Significant modulations of linc001128 and linc0938 with miR-24-3p and miR-30c-5p in Parkinson disease by Yousefi, Maryam, Peymani, Maryam, Ghaedi, Kamran, Irani, Shiva, Etemadifar, Masoud

    Published in Scientific reports (16-02-2022)
    “…Parkinson disease (PD) is the second most common neurodegenerative disease; the evidence suggests that lncRNAs and miRNAs play an important role in regulating…”
    Get full text
    Journal Article
  4. 4

    Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model by Niloofar Najarzadegan, Mahboobeh Madani, Masoud Etemadifar, Nahad Sedaghat

    Published in PloS one (07-12-2022)
    “…Fingolimod (FTY720) is a drug derived from the fungicidal compound myriocin. As it was unclear whether FTY720 has antifungal effects as well, we aimed to…”
    Get full text
    Journal Article
  5. 5

    Barriers to quality of life in patients with multiple sclerosis: a qualitative study by Hosseini, Zahra, Homayuni, Atefeh, Etemadifar, Masoud

    Published in BMC neurology (13-05-2022)
    “…Multiple sclerosis (MS) is a chronic progressive disease of the central nervous system that affects the patients' quality of life. This research was conducted…”
    Get full text
    Journal Article
  6. 6

    Span of spleen is associated with disability status in multiple sclerosis: a cross-sectional abdominopelvic ultrasonography study by Etemadifar, Masoud, Alaei, Seyyed-Ali, Salari, Mehri, Sedaghat, Nahad

    Published in Scientific reports (03-07-2024)
    “…Characteristics of livers and spleens of people with multiple sclerosis (pwMS) could constitute good biomarkers of MS-related characteristics such as the…”
    Get full text
    Journal Article
  7. 7

    Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse by Etemadifar, Masoud, Nouri, Hosein, Salari, Mehri, Sedaghat, Nahad

    Published in Human vaccines & immunotherapeutics (31-12-2022)
    “…Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a relatively unknown autoimmune entity. Scant reports of post-infection/vaccination anti-NMDAR…”
    Get full text
    Journal Article
  8. 8

    The effect of counseling based on the PLISSIT model on sexual quality of life of married women with multiple sclerosis referring to MS center in 2019: a randomized, controlled trial by Kazemi, Zahra, Mousavi, Mahsa Sadat, Etemadifar, Masoud

    Published in Archives of women's mental health (01-06-2021)
    “…Multiple sclerosis is the most common progressive neurological disability in young adults. Sexual quality of life is mainly attributed to feelings of sexual…”
    Get full text
    Journal Article
  9. 9

    miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis by Naghavian, Reza, Ghaedi, Kamran, Kiani-Esfahani, Abbas, Ganjalikhani-Hakemi, Mazdak, Etemadifar, Masoud, Nasr-Esfahani, Mohammad Hossein

    Published in PloS one (04-05-2015)
    “…One of the main issues in pathogenesis of MS is Th17/Treg imbalance. There are growing interests in nominating miRNAs involved in Th17 cell differentiation,…”
    Get full text
    Journal Article
  10. 10

    Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient by Etemadifar, Masoud, Sigari, Amirhossein Akhavan, Sedaghat, Nahad, Salari, Mehri, Nouri, Hosein

    Published in Human vaccines & immunotherapeutics (03-10-2021)
    “…With the progress of COVID-19 vaccination programs worldwide, some new adverse events associated with the available vaccines may unfold, especially in…”
    Get full text
    Journal Article
  11. 11

    Explaining the facilitators of quality of life in patients with multiple sclerosis: a qualitative study by Homayuni, Atefeh, Abedini, Sedigheh, Hosseini, Zahra, Etemadifar, Masoud, Ghanbarnejad, Amin

    Published in BMC neurology (11-05-2021)
    “…In patients with multiple sclerosis (MS), the disease's complications and manifestations affect a person's ability to function normally and leads to further…”
    Get full text
    Journal Article
  12. 12

    A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease by Fazeli, Soudabeh, Motovali-Bashi, Majid, Peymani, Maryam, Hashemi, Motahare-Sadat, Etemadifar, Masoud, Nasr-Esfahani, Mohammad Hossein, Ghaedi, Kamran

    Published in PloS one (10-11-2020)
    “…Parkinson's disease (PD) is diagnosed when motor symptoms emerges, which almost 70% of dopamine neurons are lost. Therefore, early diagnosis of PD is crucial…”
    Get full text
    Journal Article
  13. 13

    Incidence of anxiety in epilepsy during coronavirus disease (COVID-19) pandemic by Salari, Mehri, Etemadifar, Masoud, Gharagozli, Koroush, Etemad, Koorosh, Ashrafi, Farzad, Ashourizadeh, Helia

    Published in Epilepsy & behavior (01-11-2020)
    “…The coronavirus disease 2019 (COVID-19) pandemic has affected people globally, and people with chronic diseases are suffering more in maintaining their mental…”
    Get full text
    Journal Article
  14. 14

    Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing–remitting multiple sclerosis patients and their family members by Samangooei, Mahsa, Farjam, Mojtaba, Etemadifar, Masoud, Taheri, Atefeh, Meshkibaf, Mohammad Hassan, Movahedi, Bahram, Niknam, Zahra, Noroozi, Saam

    Published in Scientific reports (09-02-2022)
    “…Multiple sclerosis is an inflammatory disease of the spinal cord and brain. Receptor for advanced glycation end products and Apolipoprotein A1 (Apo-AI) have…”
    Get full text
    Journal Article
  15. 15

    Can COVID‐19 accelerate neurodegeneration? by Salari, Mehri, Etemadifar, Masoud

    Published in Clinical case reports (01-07-2021)
    “…COVID‐19 may accelerate neurodegeneration in patients with neurodegenerative disease. COVID‐19 may accelerate neurodegeneration in patients with…”
    Get full text
    Journal Article
  16. 16

    Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study by Etemadifar, Masoud, Abhari, Amir Parsa, Nouri, Hosein, Salari, Mehri, Maleki, Shiva, Amin, Alireza, Sedaghat, Nahad

    Published in BMC neurology (22-02-2022)
    “…Some current evidence is pointing towards an association between COVID-19 and worsening of multiple sclerosis (MS), stressing the importance of preventing…”
    Get full text
    Journal Article
  17. 17

    Autoimmune encephalitis: the first observational study from Iran by Etemadifar, Masoud, Aghababaei, Ali, Nouri, Hosein, Kargaran, Parisa K., Mohammadi, Shaghayegh, Salari, Mehri

    Published in Neurological sciences (01-02-2022)
    “…Background Even within the most populous countries in the Middle East, such as Iran, autoimmune encephalitis cases have been rarely reported. Objective We…”
    Get full text
    Journal Article
  18. 18

    Patent foramen ovale leading to mismanagement in a mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke‐like episodes patient by Salari, Mehri, Etemadifar, Masoud, Rashedi, Ronak, Rashedi, Romina

    Published in Clinical case reports (01-07-2023)
    “…Key Clinical Message The stroke‐like episodes and brain MRI lesions in MELAS usually have a nonischemic pattern, are resolved over time, and have a migrating…”
    Get full text
    Journal Article
  19. 19

    Effect of Aquatic Exercise Training on Fatigue and Health-Related Quality of Life in Patients With Multiple Sclerosis by Kargarfard, Mehdi, PhD, Etemadifar, Masoud, MD, PhD, Baker, Peter, PhD, Mehrabi, Maryam, MSc, Hayatbakhsh, Reza, MD, PhD

    “…Abstract Kargarfard M, Etemadifar M, Baker P, Mehrabi M, Hayatbakhsh R. Effect of aquatic exercise training on fatigue and health-related quality of life in…”
    Get full text
    Journal Article
  20. 20

    Multiple sclerosis epidemiology in Asia and Oceania; A systematic review and meta-analysis by Forouhari, Ali, Taheri, Ghazale, Salari, Mehri, Moosazadeh, Mahmood, Etemadifar, Masoud

    Published in Multiple sclerosis and related disorders (01-09-2021)
    “…•Multiple sclerosis prevalence among total population of Asia and Oceania is 37.89/100,000.•Multiple sclerosis incidence among total population of Asia and…”
    Get full text
    Journal Article